Overview

Evaluation of Skin Quality Improvement

Status:
Completed
Trial end date:
2018-07-26
Target enrollment:
Participant gender:
Summary
The purpose of this study is to comprehensively investigate and objectively demonstrate the effectiveness of hyperdiltue Botox® Cosmetic in improving overall skin quality, more specifically evenness of skin tone, reduction of pore size and improvement in the appearance of preexisting skin scars.
Phase:
Phase 2
Details
Lead Sponsor:
Steve Yoelin M.D. Medical Associates, Inc.
Collaborator:
Allergan
Treatments:
abobotulinumtoxinA
Anesthetics
Botulinum Toxins, Type A
incobotulinumtoxinA
onabotulinumtoxinA
Pharmaceutical Solutions